MIRA INFORM REPORT

 

 

Report Date :

15.06.2012

 

IDENTIFICATION DETAILS

 

Name :

P.T. MENJANGAN SAKTI

 

 

Registered Office :

Mensa Builing I, 3rd Floor Jl. Rasuna Said Kav. B-34 Kuningan Jakarta 12940

 

 

Country :

Indonesia

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

07.04.1975

 

 

Com. Reg. No.:

No. AHU-AH.01.10-13613

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Importer and Wholesale of Pharmaceutical Raw Materials, Food Ingredients, Feed Meals, Cosmetic, Medical Devices and others.

 

 

No. of Employees :

194 persons                                    

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Indonesia

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D


Name of Company

 

P.T. MENJANGAN SAKTI

 

 

Address

 

Head Office

Mensa Builing I, 3rd Floor

Jl. Rasuna Said Kav. B-34

Kuningan

Jakarta 12940

Indonesia

Phone               - (62-21) 5222468 (hunting)

Fax.                  - (62-21) 5222467, 5256337

Email                - sales@mensa-trading.com

Website            - http://www.mensa-trading.com

Building Area     - 22 storey

Office Space      - 600 sq. meters

Region              - Commercial

Status               - Owned

 

Warehouse

Jl. Pulau Kambing II/26

Pulogadung Industrial Estate

Jakarta Timur

Indonesia

Phone               - (62-21) 4605895, 46824074

Fax.                  - (62-21) 46824075

Building Area     -  3,800 sq. meters

Office Space      -  2,500 sq. meters

Region              - Industrial Estate

Status               - Rent

 

 

Registration data

 

Date of Incorporation :

07 April 1975

 

Legal Form :

P.T. (Perseroan Terbatas) or Limited Liability Company

 

Company Reg. No. :

The Ministry of Law and Human Rights

a. No. AHU-90910.ah.01.02.Tahun 2008

    Dated 27 November 2008

b. No. AHU-AH.01.10-13613

    Dated 20 August 2009

 

Company Status :

National Private Company

 

Permit by the Government Departments :

a. The Department of Finance

    NPWP No. 01.301.277.8-062.000

b. The Department of Health

    No. 405/AA/SK/PBB/II/7

    Dated 7 September 1981

c. The Department of Trade

    TAPPI No. 5749 N

    Dated 11 February 1981

 

Related Company :

The MENSA Group Members

 

 

CAPITAL AND OWNERSHIP

 

Capital Structure :

Authorized Capital             - Rp.  20,000,000,000.-

Issued Capital                   - Rp.  15,000,000,000.-

Paid up Capital                 - Rp.  15,000,000,000.-

 

Shareholders/Owners :

a. Mr. Sudharta AKA Jimmy Sudaharta   - Rp. 14,990,000,000.- (99.93%)

    Address : Jl. Caringin Timur I/20 RT.015/010

                    Jakarta Selatan

                    Indonesia

b. Mr. Budi Jonathan Sudharta               - Rp.        10,000,000.- (  0.07%)

     Address : Jl. Caringin Timur I/20 RT.015/010

                    Jakarta Selatan

                    Indonesia

 

 

BUSINESS ACTIVITIES

                             

Lines of Business:       

Importer and Wholesale of Pharmaceutical Raw Materials, Food Ingredients, Feed Meals, Cosmetic, Medical Devices and others.

 

Production Capacity :

None

 

Total Investment :

None

 

Started Operation :

1975

 

Brand Name :

MENJANGAN SAKTI or MENSA

 

Technical Assistance :

None

 

Number of Employee :

194 persons                                     

 

Marketing Area :

Local    - 100%

 

Main Customers :

a. P.T. COCA COLA INDONESIA

b. P.T. DANONE INDONESIA

c. P.T. INDOFOOD SUKSES MAKMUR Tbk.

d. P.T. NESTLE BEVERAGES INDONESIA

e. P.T. AJINOMOTO INDONESIA

f.  P.T. AVENTIS INDONESIA

g. P.T. BAYER INDONESIA

h. P.T. PFIZER INDONESIA

i.  Etc.

 

Market Situation :

Very Competitive

 

Main Competitors :

a. P.T. KHARINDO PRAKARSA

b. P.T. ELANG KURNIA SAKTI

c. P.T. ADIMITRA PRIMA LESTARI

d. P.T. TIRTA WANA SEMESTA KENCANA

e. P..T. MEGA KEMIRAYA, etc.

 

Business Trend :

Growing

 

 

BANKER, AUDITOR & LITIGATION

 

B a n k e r s :

a. The Hong Kong and Shanghai Bank Corp.

    Jakarta Office

    Jl. HR Rasuna Said Kav. X7 No. 6

    Jakarta Selatan

b. P.T. Bank CENTRAL ASIA Tbk.

    Menara Karya, Ground Floor

    Jl. HR Rasuna Said Blok X-5 Kav.1-2

   Jakarta Selatan

 

c. P.T. Bank DANAMON INDONESIA

    Menara Bank Danamon

    Jl. Prof. Dr. Satrio Kav. E4 No. 6

    Jakarta Selatan

 

Auditor :

Johan Malonda Mustika & Rekan, a public accountant

 

Litigation :

No litigation record in our database

 

 

FINANCIAL FIGURE

 

Annual Sales  :

2009 – Rp. 740.0 billion

2010 – Rp. 803.7 billion

2011 – Rp. 872.0 billion (estimated)

 

Net Profit :

2004 – Rp. 36.1 billion

2010 – Rp. 41.6 billion

2011 – Rp. 45.2 billion (estimated)

 

Payment Manner :

Average

 

Financial Comments :

Satisfactory

 

 

KEY EXECUTIVES

 

Board of Management :

President Director                      - Mr. Sudharta AKA Jimmy Sudharta

Director                                     - Mr. Budi Jonathan Sudharta

 

Board of Commissioner :

Commissioner                           - Mrs. Lanny Soenanta Sudharta

 

Signatories :

President Director (Mr. Sudharta AKA Jimmy Sudharta) or Director (Mr. Budi Jonathan Sudharta) which must be approved by the Board of Commissioner (Mrs. Lanny Soenanta Sudharta)

 

 

CAPABILITIES

 

Management Capability :

Good

 

Business Morality :

Good

 

Credit Risk :

Below Average

 

Credit Recommendation :

Credit should be proceeded normally

 

Proposed Credit Limit :

Moderate amount

 

 

OVERALL PERFORMANCE

 

P.T. MENJANGAN SAKTI (P.T. MENSA) was incorporated on April 7, 1975 in Jakarta with an authorized capital of Rp 20,000,000.- of which Rp 10,000,000.- was issued and paid up. Founders and shareholders of are Mr. Sudharta AKA Jimmy Sudharta and his wife Mrs. Maria Tanudjaja. They are Chinese origin Indonesian business family. The company's notarial act has frequently been amended. In 1978 its authorized capital was raised to Rp 100,000,000.- of which Rp 60,000,000.- was issued and paid up. In December 1992 its authorized capital was increased again to Rp 5,000,000,000.- and the issued capital to Rp 2,000,000,000.- wholly paid up.  In June 1995 the authorized capital was raised to Rp 10,000,000,000.- issued and paid up capital to Rp 7,000,000,000.-. In July 1996 the authorized capital was raised to Rp 20,000,000,000.- of which Rp. 15,000,000,000.- was issued and paid up.   Latest in July 2009, Mrs. Maria Tanudjaja pulled out and the whole shares are sold to her son Mr. Budi Jonathan Sudharta.  Since then, the shareholders of the company are Mr. Jimmy Sudharta (99.93%) and his son Mr. Budi Jonathan Sudharta (0.07%).   This amendment to Articles of Association was approved by the Minister of Law and Human Rights of the Republic of Indonesia by virtue of Decision Letter No. AHU-AH.01.10-13613 dated August 20, 2009. No changes have been effected in term of its shareholding composition and capital structures to date.

 

      P.T. MENSA is parent company of the MENSA Group, a big-size business group in the country.  MENSA Group, comprises of several companies with diversified activity such as importing and trading of pharmaceutical raw materials, food, feed and cosmetics; pharmaceutical manufacturing, medical supplies and dental equipment manufacturing; pharmaceutical and medical supplies and consumer goods distribution.

 

P.T. MENSA has been in operation since 1975 in trading, import and wholesale of pharmaceutical raw materials, food ingredient, feed meals, cosmetic, medical devices and others.  The company is appointed by a number of leading foreign companies such as DSM Nutritional Products, DSM Anti-Infective, WELDING Hamburg, COLORCON, SPI PHARMA, ARKEMA, BERACA, AIONEST, ECKART, BIOLAND, SANOFI AVENTIS, LANONIES, STELLA, INCA OIL, GREENTECH Naturally, GIVAUDAN, INOLEX, BRUNO BOCK, UNI PEX, RECORDATI, MEGGLE and others.  Today, P.T. MENSA having more than 1000 products and serving approximately 650 regular customers in pharmaceutical, food, feed and cosmetic industry throughout Indonesia.  Their main customers are PT. Coca Cola Indonesia, PT. Danone Indonesia, PT. Indofood Sukses Makmur, PT. Nestle Beverages Indonesia, PT. Ajinomotor Indonesia, PT. Aventis Indonesia, PT. Bayer Indonesia, P.T. Pfizer Indonesia, etc.  Besides, P.T. MENSA is also active in investment holding by controlling 35% shares of PT. OTTO PHARMACEUTICAL is engaged in pharmaceutical manufacturing.  We observe that P.T. MENSA is classified as a large sized company of its kind in the country of which the operation has been growing in the last three years.

 

     Generally outlook, the demand for pharmaceutical raw materials, food ingredient, feed meals, cosmetic and medical devices has kept on growing by 8% to 10% until early 1997 in line with the growing activities of pharmaceutical industries, food and beverage industries, cosmetic industries and others.  It is projected the demand will rise by about 5% to 6% per year within the coming three years. Competition is very tight due to a large number of similar local and imported products are marketed locally. Business position of P.T. MENSA is not so critical for it has controlled a wide marketing network and customers in the country.

 

      According to statement of income (source: the Department of Trade and Industry), the total sales/revenue of P.T. MENSA in fiscal 2009 amounted to Rp. 740.0 billion with a net profit of Rp. 36.1 billion increased to Rp. 803.7 billion with a net profit of Rp. 41.6 billion in 2010.  Up to present, we have yet to gain the statement of income of P.T. MENSA in fiscal 2011.  However, we estimated that net income of the company in 2011 rose again to Rp. 872.0 billion with a net profit of Rp. 45.2 billion.  The company’s balance sheets and statement of income in fiscal 2009 and 2010 are attached.   So far we did not hear that the P.T. MENSA has been black listed by Bank Indonesia (Central Bank) or having detrimental cases being settled in local district court.  The company usually pays its debts punctually to suppliers.  

 

The management is handed by Mr. Jimmy Sudharto (63), a businessman with experience for more than 32 years in the trading of pharmaceuticals raw material and pharmaceutical products. In daily activities, he is assisted by his son Mr. Budi Jonathan Sudharta AKA Jonathan Sudharta (31). The management is also handled by a number of professional staff, having maintained a wide business relation with private businessmen at home and abroad as well as with government sector. So far, we did not hear that the company’s management involved in the business malpractices or detrimental cases that settled in the country. The company’s litigation record is clean and it has not registered with the black list of Bank of Indonesia.

 

P.T. MENSA is appraised a good enough for business transaction. But owing to economic condition in the country is still unstable, we recommend to treat prudently in extending any new loan to the company.

 

                                   

 

Attachment:

 

P.T. MENJANGAN SAKTI

Financial Statement

As of 31 December 2009 and 2010

(Expressed in Rupiah/IDR)

 

DESCRIPTION

31 December

2010

2009

A. ASSETS

 

 

Current Assets

 

 

- Cash on hand and in banks

32,043,766,523

12,612,619,384

- Time Deposit

1,269,040,809

--

- Trade Receivables:

* Related Parties

* Third Parties

150,656,280,190

107,820,079,638

120,749,029,580

85,667,434,960

- Other Receivables

1,220,726,664

2,094,676,955

- Inventories

148,108,340,240

89,986,300,999

- Prepaid Taxes

--

9,559,668,816

- Advances and Prepaid Expenses

2,253,987,128

20,611,677,254

- Due from Related Parties

13,720,361,610

--

TOTAL CURRENT ASSETS

457,092,582,802

341,281,407,948

 

 

 

Non-Current Assets

 

 

- Property, Plant and Equipment - net

10,647,130,061

8,124,552,978

- Investment in Shares of Stock

59,267,946,300

41,538,326,235

- Deferred Tax Assets

3,360,131,565

5,381,167,582

- Others Asset

125,300,000

116,574,346

TOTAL NON-CURRENT ASETS

73,400,507,926

55,160,621,141

 

 

 

TOTAL ASSETS = TOTAL LIABILITIES &        

                                SHAREHOLDERS’ EQUITY

530,493,090,728

396,442,029,089

 

 

 

B. LIABILITIES & SHAREHOLDERS EQUITY

 

 

Current Liabilities

 

 

- Bank Loans

190,639,450,769

160,564,955,228

- Trade Payable

110,429,384,236

50,876,687,514

- Other Payable

1,833,670,551

3,002,552,144

- Taxes Payable

3,316,209,249

5,394,816,172

- Unearned Revenue

8,539,472

53,453,251

- Accrued Expenses

1,213,600,758

692,831,777

- consumer Financing

1,792,826,146

499,365,739

Total Current Liabilities

309,233,691,181

221,084,661,825

Non-Current Liabilities

 

 

- Estimated Liabilities for Post-Employment Benefits

12,282,453,857

10,627,469,027

- Consumer Financing

424,451,498

--

- Other Long-term Payable

15,961,018,344

13,636,602,148

Total Non-current Liabilities

28,667,923,699

24,264,071,175

 

 

 

SHAREHOLDERS’ EQUITY

 

 

- Authorized, Issued and Paid up Capital

15,000,000,000

15,000,000,000

- Revaluation Increment in fixed assets

--

164,008,860

- Retained earnings

177,591,475,848

135,929,287,229

TOTAL SHAREHOLDERS’ EQUITY

192,591,475,848

151,093,296,089

 

 

 

C. INCOME STATEMENT

 

 

    a. Net Sales/Revenue

803,666,460,751

739,956,254,287

    b. Cost of Goods Sold

(695,044,561,064)

(657,447,591,646)

    c. Gross Profit

108,621,899,687

82,508,662,641

    d. Operating Expenses

(46,203,508,071)

(37,975,235,774)

    e. Operating Income

62,418,391,616

44,533,426,867

    f.  Other Income (Charges)

(4,700,007,986)

3,187,110,428

    g. Income Before Provision for Income Tax

57,718,383,630

47,720,537,295

    h. Provision for Income Tax

(16,140,683,017)

((11,628,960,478)

    i.  Net Income / Net Profit

41,577,700,613

36,091,576,817

Remarks:  Audited by Johan Malonda Mustika & Rekan, a public accountant

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.79

UK Pound

1

Rs.86.37

Euro

1

Rs.70.07

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.